Screener
Jade Biosciences JBIO Accrued Liabilities And Other Liabilities Current
Accrued Liabilities And Other Liabilities Current at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept ck0001798749:AccruedLiabilitiesAndOtherLiabilitiesCurrent.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Liabilities, Convertible Preferred Stock and Stockholders' Equity (Deficit) | ||
| Current liabilities: | ||
| Accounts payable | 3,979 | 2,151 |
| Accrued expenses and other current liabilities | 14,852 | 9,419 |
| Related party accrued expenses and other current liabilities | 794 | 4,969 |
| Warrant liability, related party | 2,667 | — |
| Total current liabilities | 22,292 | 16,539 |
| Long-term liabilities: |
Item 1. Financial Statements.
FAQ
- What is Jade Biosciences's accrued liabilities and other liabilities current?
- Jade Biosciences (JBIO) reported accrued liabilities and other liabilities current of $14.85M in Q1 2026.
- What does accrued liabilities and other liabilities current mean?
- This represents the aggregate of short-term obligations that have been incurred but not yet invoiced or paid by the end of the reporting period. It typically includes items such as accrued payroll, professional fees, and other operational expenses essential to maintaining business continuity. Monitoring this balance helps assess the company's immediate short-term financial obligations and cash outflow requirements.
Ask your AI about Jade Biosciences's accrued liabilities and other liabilities current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude